Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Apr 27, 2026; 18(4): 115798
Published online Apr 27, 2026. doi: 10.4240/wjgs.v18.i4.115798
Published online Apr 27, 2026. doi: 10.4240/wjgs.v18.i4.115798
Figure 1 High expression of T-LAK cell-originated protein kinase in pancreatic neuroendocrine neoplasms with liver metastasis.
A: Representative immunohistochemical staining of T-LAK cell-originated protein kinase in pancreatic neuroendocrine neoplasm (pNEN) tissue samples with and without liver metastasis; B: Quantification of T-LAK cell-originated protein kinase-positive cells in pNENs with and without liver metastasis. The mean ± SD is used for data representation; C: Kaplan-Meier survival curves for patients with pNENs with and without liver metastasis, showing a significantly shorter overall survival for the liver metastasis group. aP < 0.0001. HE: Hematoxylin-eosin staining; IHC: Immunohistochemistry; TOPK: T-LAK cell-originated protein kinase; pNEN: Pancreatic neuroendocrine neoplasm; pNENsLM: Pancreatic neuroendocrine neoplasms in the live metastasis; OS: Overall survival.
- Citation: Meng M, Chen Q, Yuan M, Guo X, Ren SQ, Yuan CH. T-LAK cell-originated protein kinase promotes tumorigenesis and metastasis of pancreatic neuroendocrine neoplasms via mitogen-activated protein kinase axis activation. World J Gastrointest Surg 2026; 18(4): 115798
- URL: https://www.wjgnet.com/1948-9366/full/v18/i4/115798.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v18.i4.115798